QPARIK

Serial Number 88409011
606

Registration Progress

Application Filed
Apr 30, 2019
Under Examination
Apr 7, 2020
Approved for Publication
Feb 11, 2020
Published for Opposition
Feb 11, 2020
Registered

Trademark Image

QPARIK

Basic Information

Serial Number
88409011
Filing Date
April 30, 2019
Published for Opposition
February 11, 2020
Abandonment Date
May 8, 2023
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 8, 2023
Classes
005

Rights Holder

INCYTE HOLDINGS CORPORATION

03
Address
1801 Augustine Cut-Off
Wilmington, DE 19803

Ownership History

INCYTE HOLDINGS CORPORATION

Original Applicant
03
Wilmington, DE

INCYTE HOLDINGS CORPORATION

Owner at Publication
03
Wilmington, DE

Legal Representation

Attorney
Frances M. Jagla

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

44 events
Date Code Type Description Documents
May 8, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
May 8, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Sep 30, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 29, 2022 EX5G S SOU EXTENSION 5 GRANTED Loading...
Sep 20, 2022 EXT5 S SOU EXTENSION 5 FILED Loading...
Sep 20, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 16, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 14, 2022 EXT4 S SOU EXTENSION 4 FILED Loading...
Mar 14, 2022 EX4G S SOU EXTENSION 4 GRANTED Loading...
Mar 14, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 2, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 30, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
Sep 30, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
Sep 30, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 27, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 25, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Mar 25, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 25, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 19, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 17, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 17, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 17, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 12, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
May 12, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 11, 2020 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Apr 11, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 11, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 11, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 11, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 11, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 7, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 11, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 11, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 22, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 8, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 7, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 6, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 6, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 12, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 12, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 12, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 12, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 16, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 3, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of oncological disorders; pharmaceutical preparations for the treatment of auto-immune disorders; pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment graft versus host disorders

Classification

International Classes
005